Trade ImmunityBio, Inc. - IBRX CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.98 |
Open | 2.98 |
1-Year Change | -44.51% |
Day's Range | 2.9 - 3.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 1, 2025 | 2.93 | -0.08 | -2.66% | 3.01 | 3.23 | 2.89 |
Mar 31, 2025 | 2.98 | -0.12 | -3.87% | 3.10 | 3.12 | 2.90 |
Mar 28, 2025 | 3.10 | -0.29 | -8.55% | 3.39 | 3.42 | 3.00 |
Mar 27, 2025 | 3.32 | 0.54 | 19.42% | 2.78 | 3.35 | 2.76 |
Mar 26, 2025 | 2.75 | 0.03 | 1.10% | 2.72 | 2.77 | 2.69 |
Mar 25, 2025 | 2.72 | -0.09 | -3.20% | 2.81 | 2.84 | 2.67 |
Mar 24, 2025 | 2.82 | 0.11 | 4.06% | 2.71 | 2.86 | 2.69 |
Mar 21, 2025 | 2.69 | -0.01 | -0.37% | 2.70 | 2.76 | 2.66 |
Mar 20, 2025 | 2.72 | 0.01 | 0.37% | 2.71 | 2.81 | 2.70 |
Mar 19, 2025 | 2.73 | -0.04 | -1.44% | 2.77 | 2.79 | 2.68 |
Mar 18, 2025 | 2.78 | -0.06 | -2.11% | 2.84 | 2.84 | 2.69 |
Mar 17, 2025 | 2.87 | 0.04 | 1.41% | 2.83 | 2.97 | 2.82 |
Mar 14, 2025 | 2.84 | -0.10 | -3.40% | 2.94 | 2.96 | 2.76 |
Mar 13, 2025 | 2.87 | 0.05 | 1.77% | 2.82 | 3.00 | 2.81 |
Mar 12, 2025 | 2.84 | -0.03 | -1.05% | 2.87 | 2.95 | 2.78 |
Mar 11, 2025 | 2.79 | -0.09 | -3.12% | 2.88 | 2.89 | 2.71 |
Mar 10, 2025 | 2.89 | -0.04 | -1.37% | 2.93 | 3.03 | 2.85 |
Mar 7, 2025 | 2.97 | 0.04 | 1.37% | 2.93 | 3.04 | 2.89 |
Mar 6, 2025 | 2.96 | -0.03 | -1.00% | 2.99 | 3.13 | 2.93 |
Mar 5, 2025 | 3.04 | 0.02 | 0.66% | 3.02 | 3.07 | 2.91 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmunityBio, Inc. Company profile
ImmunityBio, Inc., a clinical-stage immunotherapy company, develops cell and immune therapies to treat cancers and infectious diseases. The company develops Anktiva (N-803), an IL-15 superagonist and PD-L1 that activates natural killer and T effector cells in combination with chemo and trodelvy to treat cancers, such as merkel cell carcinoma, advanced pancreatic cancer, and advanced triple negative breast cancer; and an albumin-linked formulation of doxorubicin (Aldoxorubicin) to treat breast cancer, hodgkin lymphoma, SCLC, sarcoma, and glioblastoma. It also develops a memory T-cell cancer vaccine to deliver tumor-associated antigens and neoepitopes; and a human adenovirus 5 COVID-19 vaccine. The company was founded in 2014 and is based in San Diego, California.Industry: | Bio Therapeutic Drugs |
3530 John Hopkins Court
SAN DIEGO
CALIFORNIA 92121
US
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com